Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Items for the Week Previous | All Articles This Week | Next
This article originally posted and appeared in  DietType 2 DiabetesSurgeryIssue 672

Diet Versus Bariatric Surgery?

Type 2 diabetes patients who follow the identical diet as post-bariatric surgery patients see similar reduction in blood glucose levels as those who undergo the surgery.... 
Advertisement

A controlled, prospective study following 10 patients during two periods was conducted to look at the improvements in diabetes both pre- and post- gastric bypass surgery. During both periods the same diet of less than 2000 calories was maintained by patients, with the only difference being the Roux-en-Y gastric bypass surgery during the second period, months later.

Fasting blood glucose levels dropped an average of 21 percent due to diet only and 12 percent after combining the diet with surgery.

Researchers suggest that the results indicate that the restrictive diet is responsible for the diabetes remission, not the surgery itself. However, it is hard for diabetics to maintain the restrictive diet in the absence of bariatric surgery.

Although undergoing bariatric surgery to maintain dietary control in diabetics is appealing, any surgery presents with risks of infections and complications. Patients and clinicians will need to take heed of this information and weigh the benefits and risks associated with surgery.

Lingvay, E. Guth, A. Islam, E. Livingston. Rapid Improvement of Diabetes After Gastric Bypass Surgery: Is It the Diet or Surgery? Diabetes Care, 2013; DOI: 10.2337/dc12-2316 

Advertisement


 

Bookmark and Share | Print | Category | Home

This article originally posted 12 April, 2013 and appeared in  DietType 2 DiabetesSurgeryIssue 672

Past five issues: Issue 751 | Humulin Insulin Special Edition October 2014 | Diabetes Clinical Mastery Series Issue 210 | Issue 750 | Diabetes Clinical Mastery Series Issue 209 |

2014 Most Popular Articles:

FDA Approves Once-Weekly GLP-1 Diabetes Treatment Regimen for T2DM
Posted September 25, 2014
Stanley Schwartz, MD: A New Way of Classifying Diabetes - The Beta-Cell Centric Approach
Posted September 29, 2014
Two Positive Phase 3 Trials for ITCA 650 (Exenatide, a GLP-1 Agonist) in Type 2 Diabetes
Posted October 10, 2014
GLP-1 Agonist Medications Chart
Posted September 23, 2014
EASD: Insulin Pumps Lower Mortality Rate 29% Compared to Multiple Injections in T1DM
Posted October 03, 2014
FDA Approves an Eye Drug for Diabetic Patients
Posted September 25, 2014
Handbook of Diabetes, 4th Edition, Excerpt #11: Diabetic Ketoacidosis, Hyperglycaemic Hyperosmolar State and Lactic Acidosis
Posted September 27, 2014
Best Glycemic Control for T2DM Attained with GLP-1 Agonist + Insulin
Posted September 25, 2014
Best Insulin Regimen for Type 1's
Posted October 10, 2014
Non-Caloric Artificial Sweeteners May Induce Glucose Intolerance
Posted October 10, 2014


Browse by Feature Writer & Article Category.
A. Lee Dellon, MD | Aaron I. Vinik, MD, PhD, FCP, MACP | Beverly Price | Charles W Martin, DD | Derek Lowe, PhD | Dr. Brian Jakes, Jr. | Dr. Fred Pescatore | Dr. Tom Burke, Ph.D | Eric S. Freedland | Evan D. Rosen | Ginger Kanzer-Lewis | Greg Milliger | Kristina Sandstedt | Laura Plunkett | Leonard Lipson, M.A. | Louis H. Philipson | Maria Emanuel Ryan, DDS, PhD | Marilyn Porter, RD, CDE | Melissa Diane Smith | Michael R. Cohen, RPh, MS, ScD, FASHP | Paul Chous, M.A., OD | Philip A. Wood PhD | R. Keith Campbell, Professor, B.Pharm, MBA, CDE | Richard K. Bernstein, MD | Sheri R. Colberg PhD | Sherri Shafer | Stanley Schwartz, MD, FACP, FACE | Steve Pohlit | Steven V. Edelman, M.D. | Timothy S. Hollingshead |

Cast Your Vote
Do your teenage patients manage their diabetes well?
CME/CE of the Week
Ronald Tamler, MD, PhD, MBA

Category: General Diabetes
Credits: .75
Search Articles On Diabetes In Control